Latest News

(UroToday.com) Dr. Cyrill Rentsch, University Hospital Basel Department of Urology, Switzerland presented “Results of a Phase I/II Single-Arm Clinical Trial Assessing Efficacy, Safety and Tolerability of the Recombinant Bacillus Calmette Guérin VPM1002BC in Patients with Non-Muscle-Invasive Bladder Cancer Recurrence after BCG Induction With or Without BCG Maintenance Therapy – SAKK 06/14.”

(UroToday.com) FGFR3 has been one of the most heavily studied and scrutinized proteins along the continuum of urothelial carcinogenesis.  Mutations in receptor tyrosine kinases have been described in up to 30% of muscle-invasive bladder cancer (MIBC), with FGFR3 being implicated in more than 50% of these cases.  Rates of FGFR3 mutations vary considerably by stage […]

In recent years there have been more studies dedicated to Peyronie’s disease (PD). However, prevalence and incidence are likely underestimated, with limited information on regional variation in the rate of diagnosis.

Penile plication is highly successful in appropriately selected patients with Peyronie’s disease; however, a minority of patients experience residual curvature or delayed recurrence of curvature. Revision surgery outcomes are seldomly reported.

Our aim is to provide a narrative review regarding the prevalence, the associated pathophysiologic pathways and the potential management methods of sexual dysfunction related to ablative surgical techniques for Benign Prostatic Enlargement (BPE).

Few studies have been published on erectile function after IPAA and, unlike in women, male fertility after IPAA has never been assessed. The primary objective was to assess the impact of ileal pouch-anal anastomosis (IPAA) on erectile function.

Erectile dysfunction (ED) is a common sexual disorder in adult males and one of the most important factors affecting their quality of life and that of their partners. Although PDE5 inhibitors (PDE5is) are the first choice for improving erectile function, there is a substantial proportion of ED patients, termed PDE5i nonresponders, who do not respond […]

Greenlight laser prostate vaporization is considered a valid alternative to transurethral prostate resection (TURP) for patient with LUTS due to BPH. The current review highlights the current evidence on greenlight technique and current state of-the-art.

Anatomic changes that coincide with aging including benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) negatively impact quality of life. Use of MRI with its exquisite soft tissue contrast, full field-of-view capabilities, and lack of radiation is uniquely suited for quantifying specific lower urinary tract features and providing comprehensive measurements such as total […]

To determine if same day catheter removal is feasible in select population after holmium laser enucleation of the prostate (HoLEP). We performed an analysis of patients undergoing HoLEP at our institution who underwent same-day catheter removal after HoLEP.